Personalized medicine is particularly important for disease treatment whereby many clinically used drugs exhibit a large interindividual pharmacokinetic and pharmacodynamic variability. This variability can lead to therapeutic failure or severe toxicity. Understanding of how genetic variations influence drug disposition and action could help in disease therapy based on individual’s genetic makeup. Pharmacogenomics is the study of how variations in the human genome affect the response to medications.
Pharmacogenomics is the study of how variations in the human genome affect the response to medications.
CD Genomics provides a predesigned panel, which covers 137 pharmacogenomics related genes for children. Utilizing amplicon sequencing technology by illumina system can provide more efficient and accurate targeting for the 137 genes and mutations. This panel can help to guide for selecting appropriate drugs and dosage for individual patients, for achieving personalized medication. If necessary, you can choose genes that fit your requirements.
Diseases associated with the 137 genes, including psychiatry, neurology, rheumatology, immunology, cardiovascular, oncology, pain, infection, respiratory, gastroenterology, endocrinology, hematology.
(check the Drug Safety for Children Panel Gene List for more genes)
We provide customized bioinformatics analysis including:
CD Genomics provides the accurate and cost-effective pharmacogenomics sequencing and bioinformatics analysis. Our professional expert team executes quality management, following every procedure to ensure confident and unbiased results. The general workflow for pharmacogenomics sequencing is outlined below.
For more information about the pharmacogenomics testing or need other amplification requirements, please contact us.